HemaSphere is an open access journal dedicated to support hematology patient care, research and education worldwide. EHA’s new journal intends to publish results of highly relevant basic, translational and clinical research in hematology. In addition to original research, it will also publish review and guideline articles, as well as insightful discussions of research and hematology news.
HemaSphere will be under the editorial leadership of Co-Editors-in-Chief, Dr Andreas Engert of University of Cologne and Dr Jan Cools of KU Leuven. “HemaSphere will be a new forum to publish the best research and updates on new developments in the hematology field,” said Dr Cools. “It will not be just another ‘bloody’ journal. It is a new and different open access journal, with an innovative review process leading to rapid publication and with insightful discussions and summaries of new developments in the hematology field,” he added.
HemaSphere aims to be the premier hematology information resource and will include a section titled HemaTopics. This section will present insightful discussions on all aspects related to hematology, including summaries of important articles, reports of new therapies, discussions on EU policy, and other hematology news items.
The journal will be opening for manuscript submissions on June 22. Find more information about HemaSphere.